Previous studies have shown that NGFR is linked to WNT/β-catenin signalling and activates ovarian cancer tumour spread [33], while CYP1A1 was shown to be overexpressed in ovarian cancer clinical samples and to play a carcinogenic role [34]. Here, CYP1A1 is linked to ovarian cancer.